N
IMMU

Nuveen’s Immunomedics Inc IMMU Stock Holding History

Nuveen’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,442,412
Closed -$123M – 3403
2020
Q3 		$123M Buy
1,442,412
+374,181
+35% +$18.9M 0.05% 317
2020
Q2 		$37.9M Buy
1,068,231
+287,043
+37% +$8.39M 0.02% 660
2020
Q1 		$10.5M Buy
781,188
+66,216
+9% +$1.11M 0.01% 1258
2019
Q4 		$15.1M Sell
714,972
-3,544
-0.5% -$62.5K 0.01% 1338
2019
Q3 		$9.53M Buy
718,516
+48,387
+7% +$711K ﹤0.01% 1604
2019
Q2 		$9.29M Buy
+670,129
New +$10.1M ﹤0.01% 1652
2019
Q1 		– Sell
-64,912
Closed -$926K – 1095
2018
Q4 		$926K Sell
64,912
-2,470
-4% -$49K 0.01% 734
2018
Q3 		$1.4M Buy
+67,382
New +$1.6M 0.01% 704

Nuveen's IMMU Position: Q4 2020 in Review

Nuveen sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 1,442,412 shares — an estimated $123M sold.

Nuveen first reported a position in IMMU in Q3 2018 and held it in 8 quarters. The position peaked at $123M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Nuveen reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Nuveen sold 1,442,412 Immunomedics Inc shares in Q4 2020, an estimated $123M.
  • Nuveen first reported a position in Immunomedics Inc in Q3 2018 and held it in 8 quarters.
  • Nuveen's Immunomedics Inc position peaked at $123M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Nuveen's 13F filing for Q4 2020, filed 16 Feb 2021.